Price target
45.000.00 0.00%
The 5 analysts offering 1 year price forecasts for CERE have a max estimate of — and a min estimate of —.
Analyst rating
Based on 6 analysts giving stock ratings to CERE in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
CERE EPS for the last quarter is −0.73 USD despite the estimation of −0.66 USD. In the next quarter EPS is expected to reach −0.66 USD. Track more of Cerevel Therapeutics Holdings, Inc. financials and stay on top of what is up with the company.
In the next quarter Cerevel Therapeutics Holdings, Inc. revenue is expected to reach 0 USD. Check out Cerevel Therapeutics Holdings, Inc. revenue and earnings and make informed decisions.
According to analysts, CERE price target is 45.00 USD with a max estimate of 45.00 USD and a min estimate of 45.00 USD. Check if this forecast comes true in a year, meanwhile watch Cerevel Therapeutics Holdings, Inc. stock price chart and keep track of the current situation with CERE news and stock market news.
We've gathered opinions of 6 analysts rating CERE stock in the past 3 months. Most of them backed up the neutral trend, and after taking into account other opinions, the overall rating was calculated as neutral. Note that it's not a trading advice — your own analysis is still required.